Roche Holding Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AAPL | Apple | Outperform |
16
|
$190.90 | $200.65 | 6.27% | 12 | $2.93T |
| LLY | Eli Lilly and | Outperform |
16
|
$802.91 | $636.99 | 9.29% | 9 | $722.94B |
| AVGO | Broadcom | Outperform |
8
|
$1.39k | $1.21k | 12.05% | 11 | $645.19B |
| ABBV | AbbVie | Outperform |
9
|
$159.61 | $178.42 | 14.34% | 11 | $281.85B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£123.60 | £165.99 | 36.47% | 16 | £191.61B |
| DHR | Danaher | Outperform |
10
|
$267.19 | $260.33 | 1.96% | 4 | $197.90B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.82 | $118.92 | 19.25% | 7 | $182.35B |
| GE | General Electric | Buy |
8
|
$160.81 | $144.00 | 11.95% | 3 | $176.02B |
| AMGN | Amgen | Outperform |
4
|
$309.41 | $303.65 | 3.42% | 8 | $165.98B |
| BSX | Boston Scientific | Buy |
11
|
$75.37 | $70.14 | 8.80% | 6 | $110.81B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$42.34 | $58.15 | 27.54% | 10 | $85.83B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.80 | $87.82 | 17.99% | 14 | $84.47B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$234.45 | $284.47 | 19.43% | 8 | $67.76B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.43k | ¥5.24k | 9.66% | 0 | ¥10.40T |
| MMM | 3M | Hold |
10
|
$101.49 | $109.39 | 1.98% | 3 | $56.16B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥4.85k | ¥4.92k | 25.88% | 0 | ¥7.97T |
| DXCM | DexCom Inc | Buy |
12
|
$130.53 | $125.98 | 16.56% | 2 | $51.91B |
| A | Agilent Technologies | Outperform |
10
|
$152.87 | $138.82 | -1.22% | 10 | $44.80B |
| ALC | Alcon | Outperform |
8
|
CHF82.44 | CHF90.64 | 17.50% | 3 | CHF40.76B |
| CTVA | Corteva | Outperform |
12
|
$56.98 | $61.72 | 14.08% | 1 | $39.71B |
| DD | DuPont de Nemours | Outperform |
17
|
$78.55 | $75.38 | 7.18% | 14 | $32.84B |
| BIIB | Biogen | Outperform |
10
|
$225.21 | $299.62 | 29.66% | 13 | $32.79B |
| BAYN | Bayer | Hold |
5
|
28.40€ | 45.15€ | 5.63% | 4 | 27.90€B |
| 7751 | Canon | Hold |
18
|
¥4.28k | ¥3.74k | -11.24% | 0 | ¥3.69T |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.06k | kr2.71k | 27.98% | 14 | kr132.66B |
| BGNE | BeiGene | Buy |
6
|
$167.92 | $285.19 | 60.20% | 2 | $17.56B |
| CE | Celanese | Hold |
13
|
$153.21 | $148.23 | 9.00% | 18 | $16.73B |
| BIM | bioMérieux | Outperform |
18
|
94.40€ | 105.55€ | 21.82% | 1 | 11.73€B |
| TECH | Bio-Techne Corp | Buy |
16
|
$82.98 | $100.78 | 1.83% | 2 | $12.55B |
| 4523 | Eisai | Outperform |
18
|
¥6.59k | ¥9.58k | 27.41% | 0 | ¥1.97T |
| FME | Fresenius Medical Care AG & Co... | Hold |
18
|
38.75€ | 41.13€ | 0.65% | 12 | 11.38€B |
| ERF | Eurofins Scientific | Hold |
18
|
59.88€ | 0.00€ | 0.20% | 5 | 11.05€B |
| BRKR | Bruker | Outperform |
16
|
$78.29 | $73.64 | 9.85% | 1 | $11.08B |
| EXAS | Exact Sciences | Buy |
8
|
$53.49 | $90.32 | 58.91% | 7 | $9.96B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.03 | £65.12 | 8.44% | 6 | £6.81B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$291.84 | $536.80 | 41.86% | 1 | $7.92B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$102.71 | $85.71 | 16.83% | 5 | $6.78B |
| EXEL | Exelixis | Outperform |
16
|
$21.00 | $26.44 | 28.57% | 5 | $6.34B |
| GETI B | Getinge AB | Outperform |
18
|
kr185.65 | kr226.10 | 21.73% | 3 | kr63.33B |
| DIA | DiaSorin S.p.A. | Outperform |
18
|
99.40€ | 102.04€ | 1.56% | 1 | 5.26€B |
| CLN | Clariant | Outperform |
18
|
CHF14.76 | CHF16.11 | 8.40% | 6 | CHF4.67B |
| BIOCON | Biocon | Hold |
14
|
Rp307.95 | Rp270.86 | -5.83% | 14 | Rp365.06B |
| ALKS | Alkermes | Outperform |
10
|
$24.21 | $33.27 | 32.18% | 3 | $4.11B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$11.40 | HK$3.96 | -66.32% | 0 | HK$26.30B |
| 002773 | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥22.77 | ¥24.00 | -100.00% | 1 | ¥21.63B |
| EKTA B | Elekta AB (publ) | Hold |
18
|
kr86.95 | kr83.00 | -10.29% | 3 | kr30.26B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.37 | $9.50 | 49.14% | 5 | $2.55B |
| DCPH | Deciphera Pharmaceuticals | Hold |
6
|
$25.48 | $23.40 | 2.04% | 4 | $2.19B |
| 300676 | BGI Genomics | - |
17
|
¥40.65 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$6.66 | $14.09 | 65.17% | 2 | $1.09B |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$3.46 | $8.67 | 58.96% | 2 | $515.79M |
| DHG | DHG Pharmaceutical Joint Stock | Hold |
18
|
115.80k | 125.44k | 0.68% | 0 | 14.92T |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.11 | $10.86 | 279.15% | 3 | $255.37M |
| ALIM | Alimera Sciences | Buy |
9
|
$3.00 | $7.00 | 166.67% | 3 | $171.72M |
| DBD | Binh Dinh Pharmaceutical and M... | Outperform |
15
|
₫52.60k | ₫62.90k | 10.27% | 1 | ₫3.97T |
| DCL | Cuu Long Pharmaceutical Joint ... | - |
12
|
₫30.05k | ₫0.00 | -100.00% | 0 | ₫1.97T |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£28.91 | £0.00 | -100.00% | 0 | £3.30B |
| DMC | Domesco Medical Import - Expor... | - |
0
|
₫56.20k | ₫0.00 | -100.00% | 0 | ₫1.74T |
| BNGO | Bionano Genomics | Outperform |
6
|
$1.11 | $12.33 | 440.54% | 2 | $65.69M |
| AGL | ANGLE | Buy |
8
|
£0.19 | £0.97 | 263.16% | 0 | £46.23M |
| DRIO | DarioHealth | Buy |
6
|
$1.74 | $4.70 | 187.36% | 1 | $54.88M |
| BCART | Biocartis Group NV | - |
7
|
0.29€ | 1.10€ | -100.00% | 0 | 27.24€M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$1.05 | $5.00 | -100.00% | 1 | $19.07M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp118.90 | Rp0.00 | -100.00% | 0 | Rp897.11M |
| DBT | Ben Tre Pharmaceutical Joint S... | - |
8
|
₫12.60k | ₫0.00 | -100.00% | 0 | ₫207.33B |
| ACOR | Acorda Therapeutics | - |
5
|
$0.72 | $200.00 | -100.00% | 1 | $0.53M |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |